Experts at Royal Brompton and Harefield hospitals care for patients with a wide range of complex cardiac conditions, including congenital (present at birth), inherited and acquired later in life.
Our work
Royal Brompton and Harefield hospitals are the world’s leading centre for congenital heart disease research and a national and international training centre for cardiologists, cardiothoracic surgeons and other clinicians, treating patients from birth through to adulthood. The adult congenital heart disease (ACHD) unit at Royal Brompton is one of the largest specialist centres in the world.
We have one of the fastest primary angioplasty services in the UK at Harefield’s Heart Attack Centre, and offer the largest implantable cardiac device (ICD) service in the UK (including pacemakers and defibrillators).
Our transcatheter aortic valve implantation (TAVI) service enjoys an international reputation. TAVI is a non-surgical alternative to open-heart surgery for patients with a narrowed aortic valve and is carried out in the Trust’s ground-breaking hybrid theatre.
Our pulmonary hypertension service is one of nine designated in the country that form the National Pulmonary Hypertension Service (NPHS) for England.
Royal Brompton and Harefield hospitals are both ranked highly among the top 100 specialist cardiology hospitals in the world, according to Newsweek magazine's 'World's Best Specialized Hospitals 2026'. Both hospitals have been named in the top 10 hospitals in the UK for cardiology and cardiac surgery since the list was created in 2021.